Researchers at Dana-Farber Cancer Institute introduced MARLIN, an innovative diagnostic technology combining DNA methylation profiling with machine learning to rapidly classify acute leukemia subtypes. This method surpasses limitations of traditional morphological and immunophenotyping techniques, accelerating diagnosis and enabling precision treatment. The integration of epigenetics and AI represents a significant breakthrough in hematologic malignancy diagnostics, poised to improve clinical workflows and patient outcomes.